Outcomes in B cell non-Hodgkin lymphoma patients who underwent autologous stem cell transplantation following rituximab containing conditioning regimens in partial remission.
Study #: LY18-01b
Study Status: Published
Presentation(s)
2020, ASCO (Oral)